MX9707121A - Formulaciones liquidas de gch. - Google Patents

Formulaciones liquidas de gch.

Info

Publication number
MX9707121A
MX9707121A MX9707121A MX9707121A MX9707121A MX 9707121 A MX9707121 A MX 9707121A MX 9707121 A MX9707121 A MX 9707121A MX 9707121 A MX9707121 A MX 9707121A MX 9707121 A MX9707121 A MX 9707121A
Authority
MX
Mexico
Prior art keywords
compositions
liquid formulations
stabilised
hcg
hcg liquid
Prior art date
Application number
MX9707121A
Other languages
English (en)
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Priority to MX9707121A priority Critical patent/MX9707121A/es
Publication of MX9707121A publication Critical patent/MX9707121A/es

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La invencion se refiere a composiciones farmacéuticas, liquidas que contienen GCH estabilizada con un polialcohol o un azucar no reductor. De preferencia, las composiciones son estabilizadas con manitol. En las modalidades preferidas tales composiciones son soluciones acuosas en una solucion amortiguadora de fosfato con un pH de 7. Tales composiciones están listas para ser inyectadas y, por lo tanto, la etapa de reconstitucion del polvo liofilizado se evita, de esta forma simplificando la forma de uso.
MX9707121A 1997-09-19 1997-09-19 Formulaciones liquidas de gch. MX9707121A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9707121A MX9707121A (es) 1997-09-19 1997-09-19 Formulaciones liquidas de gch.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9707121A MX9707121A (es) 1997-09-19 1997-09-19 Formulaciones liquidas de gch.

Publications (1)

Publication Number Publication Date
MX9707121A true MX9707121A (es) 1998-06-30

Family

ID=39491358

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707121A MX9707121A (es) 1997-09-19 1997-09-19 Formulaciones liquidas de gch.

Country Status (1)

Country Link
MX (1) MX9707121A (es)

Similar Documents

Publication Publication Date Title
IL133220A0 (en) Stabilized antibody formulation
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
MXPA03000046A (es) Interleucina-2 estabilizada.
PL313084A1 (en) Pharmaceutic formulation of nerve growth factor
IL106750A0 (en) Peg interferon conjugates
HU9401831D0 (en) Stabilized pharmaceutical formulations comprising growth hormone and asparagine
EP0454044A3 (en) Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
HUP0100090A2 (hu) Szájápoló készítmények
IE891032L (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
MX9603515A (es) Preparacion farmaceutica que contiene activadores de plasminogeno.
AU2670495A (en) Ifn-beta liquid formulations
WO2001045650A3 (de) Kosmetische verwendung von rückständen aus der weinherstellung
IE880183L (en) Thrombin preparations
ATE157256T1 (de) Il-6 enthaltende pharmazeutische zusammensetzungen stabilisiert mit einem nicht- reduzierenden zucker
PL340731A1 (en) Single-dose syringe of less than 0.5 ml cubic content containing lyophilised protein composition
MX9707121A (es) Formulaciones liquidas de gch.
MY123805A (en) Stabilized pharmaceutical composition based on quinupristine and dalfopristine and their preparation.
ES8501982A1 (es) Un procedimiento para obtener una composicion farmaceutica liofilizada a base de interferon y un aminoacido estabilizante.